The U.S. FDA’s Accreditation Scheme for Conformity Assessment (ASCA) program has its benefits, but industry had some sharp words for the agency in commenting on the 2024 ASCA draft guidance. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback